Scott A. Gangloff - Apr 29, 2024 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Signature
/s/ Jonathan Young, Attorney-in-fact
Stock symbol
AKRO
Transactions as of
Apr 29, 2024
Transactions value $
$0
Form type
3
Date filed
5/1/2024, 07:32 PM
Next filing
Dec 18, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney